Mello, Luiz Eugênio Araújo de MoraesQueiroz, Claudio Marcos Teixeira de2017-11-272017-11-272005QUEIROZ, Claudio Marcos Teixeira de. Contribuição das proteínas tirosina cinases e da cálcio-calmodulina cinase tipo II em modelos animais de epilepsia. 2005. 123 f. Tese (Doutorado) - Programa de Pós-graduação em Neurologia e Neurociências, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 2005.https://repositorio.ufrn.br/jspui/handle/123456789/24378Temporal lobe epilepsies are highly refractory to pharmacological treatment. Up to 70% of these patients undergo chirurgical resection of temporal region, procedure with important consequences for the social, economic and psychological spheres. Experimental animal models that mimic temporal lobe epilepsy provide an insightful approach to study the neural basis of epilepsy as well as create opportunities to test promising therapeutic drugs. The present thesis tests the antiepileptogenic activity of two protein tyrosine kinase inhibitors and the relevance of Ca+2/calmodulin kinase type II (CaMKII) mutants. Multiples morphological and physiological alterations take place after a traumatic brain injury (in this thesis, the status epilepticus) leading the animal to an epileptic conditions. During this period, the epileptogenesis process, there is strong tyrsine phosphorylation with the activation of many second messengers. The first two chapters of the thesis describe experiments in which herbimycin A and K-252a, two protein tyrosine kinase inhibitors, were used to attenuate synaptic plasticity and epileptogenesis. The third chapter, the dentate gyrus network was studied after angular bundle stimulation in animals presenting one punctual mutation at the autoinhibitory phosphorylation site of the CaMKII. In the first chapter, we showed that one single herbimycin A injection (348μM, 5μL, icv) was able to attenuate long-term potentiation (LTP) in the commissural CA3 neurons and also, to decrease status epilepticus- (SE-) induced neuronal activation (c-Fos expression) in almost 40%. Although markedly acute effects, the present herbimycin A treatment was not able to diminish spontaneous seizure frequency, cell death or aberrant mossy fiber sprouting observed after the pilocarpine-induced SE. Curiously, herbimycin-treated animals presented decreased neo-Timm staining in the hilus and CA3 region despite the epileptic condition. In the second chapter, we confirmed the ability of protein tyrosine kinase inhibitors to decrease SE-induced neuronal activation. Herbimycin A icv treatment altered the kainic acid-induced epileptiform profile in EEG recordings. Cell death pattern was not altered by any pharmacological treatment. These results suggest that protein tyrosine kinase inhibitiors are able to modify the acute neuronal activation and plasticity (ictogenesis or LTP) but is ineffective in attenuating the epileptogenesis process. In the third chapter, we studied the dentate gyrus excitability and plasticity after angular bundle stimulation in CaMKII mutant animals. Once in its self-sustained mode, this mutation does not allow the reduction of the catalytic activity of the kinase. These animals present normal electrophysiological profiles (similar to wild-type animals) but with reduced amplitude. Shortterm plasticity was clearly altered. Mutant animals presented increased variability in the responses to trains of stimulation at 1 and 2 Hz, and at at 5Hz stronger paired-pulse inhibition. Accordingly to the literature, we also showed that the epileptiform susceptibility depends on the stimulation pattern used in both animals (mutants vs. wild-type). Thus, although the mutation did not altered the behavior and the electrographic kindling evolution, we showed that mutant animals were prone to afterdischarges when stimulate by an intermittent theta-burst stimulation. On the other hand, the same animals needed more bursts to induce afterdischarges when the stimulation was set in the continuos mode. Taken together, the present results contribute to a better understanding of the protein tyrosine kinase and CaMKII function in neuronal plasticity underlying the epileptogenesis process and sum efforts in searching for a clinic antiepileptogenic drug.Acesso AbertoEpileptogêneseHerbimicina AMorte celularBrotamento das fibras musgosasEletrofisiologiaAnimais transgênicosEpileptogenesisHerbimycin ACell deathBudding of mossy fibersElectrophysiologyTransgenic animalsContribuição das proteínas tirosina cinases e da cálciocalmodulina cinase tipo II em modelos animais de epilepsiaInvolvement of protein tyrosine kinases and calcium/calmodulin kinase type II in animal models of epilepsydoctoralThesis